Insulet Corp (NASDAQ:PODD)
| 198.63 Delayed Data As of May 20 |  +3.98 / +2.04%Today’s Change | 181.00 Today|||52-Week Range 324.81 | -25.35% Year-to-Date |
Latest PODD News | Press Releases
| Insulet (PODD) Q1 Earnings Surpass Estimates, Margins Grow May 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 194.74 |
| Today’s open | 198.75 |
| Day’s range | 191.77 - 199.99 |
| Volume | 344,403 |
| Average volume (3 months) | 617,420 |
| Market cap | $13.8B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +136.38% |
| Earnings growth (this year) | +442.32% |
| Earnings growth (next 5 years) | +73.00% |
| Revenue growth (last year) | +21.49% |
| P/E ratio | 310.4 |
| Price/Sales | 16.61 |
| Price/Book | 24.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -0.31 | -0.11% |
| ABMDABIOMED Inc | -2.90 | -1.22% |
| SAUHFStraumann Holding AG | -3.90 | -3.26% |
| ---- |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $16.8M |
| Net profit margin | 1.53% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Acton, Massachusetts |
Forecasts
